2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Bone Morphogenetic Protein 7: new trials by email Literature Review of Bone Morphogenetic Protein 7 trials Research Report on Bone Morphogenetic Protein 7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee Bone morphogenetic protein 7 - Osteoarthritis of the Knee | Phase 1 | Completed | Stryker Biotech | 51 | 2010-05-01 | 2012-02-01 |
| Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee Bone morphogenetic protein 7, Placebo - Osteoarthritis of the Knee | Phase 2 | Completed | Stryker Biotech | 355 | 2010-04-01 | 2012-02-01 |
| A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union BMP-7 in adjunct to fresh frozen allograft, allograft together with DBM - Non-union Diaphysary Tibial Fractures | Phase 4 | Terminated | University Hospital, Ghent | 2 | 2007-10-01 | 2021-07-08 |
Stryker Biotech (2) · University Hospital, Ghent (1)
United States (2) · Belgium (1)